- Home
- ONEW vs DRUG Comparison
ONEW vs DRUG Comparison
Compare ONEW & DRUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONEW
- DRUG
- Stock Information
- Founded
- ONEW 2014
- DRUG 2019
- Country
- ONEW United States
- DRUG United States
- Employees
- ONEW N/A
- DRUG N/A
- Industry
- ONEW Auto & Home Supply Stores
- DRUG Pharmaceuticals and Biotechnology
- Sector
- ONEW Consumer Discretionary
- DRUG Health Care
- Exchange
- ONEW Nasdaq
- DRUG Nasdaq
- Market Cap
- ONEW 244.4M
- DRUG 233.2M
- IPO Year
- ONEW 2020
- DRUG N/A
- Fundamental
- Price
- ONEW $14.77
- DRUG $25.95
- Analyst Decision
- ONEW Buy
- DRUG Strong Buy
- Analyst Count
- ONEW 7
- DRUG 6
- Target Price
- ONEW $19.83
- DRUG $83.25
- AVG Volume (30 Days)
- ONEW 180.1K
- DRUG 29.2K
- Earning Date
- ONEW 07-29-2025
- DRUG 05-15-2025
- Dividend Yield
- ONEW N/A
- DRUG N/A
- EPS Growth
- ONEW N/A
- DRUG N/A
- EPS
- ONEW N/A
- DRUG N/A
- Revenue
- ONEW $1,779,631,000.00
- DRUG N/A
- Revenue This Year
- ONEW $1.77
- DRUG N/A
- Revenue Next Year
- ONEW $4.88
- DRUG N/A
- P/E Ratio
- ONEW N/A
- DRUG N/A
- Revenue Growth
- ONEW N/A
- DRUG N/A
- 52 Week Low
- ONEW $11.58
- DRUG $0.93
- 52 Week High
- ONEW $31.36
- DRUG $79.02
- Technical
- Relative Strength Index (RSI)
- ONEW 52.57
- DRUG 30.05
- Support Level
- ONEW $13.41
- DRUG $26.30
- Resistance Level
- ONEW $15.00
- DRUG $31.20
- Average True Range (ATR)
- ONEW 0.72
- DRUG 2.50
- MACD
- ONEW 0.07
- DRUG -0.55
- Stochastic Oscillator
- ONEW 55.60
- DRUG 5.59
About ONEW OneWater Marine Inc.
OneWater Marine Inc is a recreational marine retailer in the United States. The company operates in two segments: Dealership and Distribution. The Dealership segment is involved in selling new and pre-owned boats. It also arranges financing and insurance products, provides repairs and maintenance services, offers marine-related parts and accessories, and supplies slip and storage accommodations at certain locations. The Distribution segment focuses on the manufacturing, assembly, and distribution of marine-related products. These products are supplied to distributors, box retailers, and online retailers through a network of warehouses and distribution centers. The company generates the majority of its revenue from the Dealership segment.
About DRUG Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.